Premium
Three‐month formulation of paliperidone delays relapse in schizophrenia
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30060
Subject(s) - paliperidone palmitate , paliperidone , schizophrenia (object oriented programming) , medicine , placebo , antipsychotic , psychiatry , alternative medicine , pathology
A long‐acting injectable formulation of the antipsychotic paliperidone palmitate significantly delayed time to relapse in a placebo‐controlled study of patients with schizophrenia who had been stabilized on the injectable medication, a new study has found.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom